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ABSTRACT 
Background  
Oral cancer is characterised by marked geographical differences in frequency and site 
preference as reported by various studies. 
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In South Africa, a few studies have been reported on the patterns and aetiology of oral cancer, 
and age standardised incidence rates (ASIR). Studies in several countries have shown an 
increase in oral cancer incidence among younger people. 
Title: Epidemiology of oral cancer in South Africa 1996-2002. 
Aim and Objective: The aim of this study was to determine the age standardised incidence 
rates (ASIR) of oral cancer by age, gender, race and site in South Africa for a consecutive 
period of seven years.  
Method: Pathology case records of oral cancer diagnosed over a seven-year period from 1996 
to 2002 and reported to the National Cancer Registry (NCR) were analysed for age, sex, race, 
and date of diagnosis, basis of diagnosis, topography and tumour type. The data was 
tabulated and categorised using Microsoft Excel. The South African population size for each 
year of the study was estimated by linear extrapolation using the 1996 and 2001 census 
results. Age standardisation incidence rates against the world population were calculated by 
the standard direct method. 
Results: The total number of oral squamous cell carcinoma cases over the 7-year period was 
9702. The majority of cases (34%) were on the tongue. The male to female ratio was 1:3. The 
age standardized incidence rates in this study was lower among African women; (0.640 per 
100000 per year) and the highest was 13.40 new cases per 100000 per year (coloured males).  
Lip cancer was highest among both males and females of the white population. The 
cumulative rate of developing oral cancer was 1:83 and 1:32 for males and females 
respectively.  
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INTRODUCTION 
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Cancer is one of the most important medical problems in today’s world. A great proportion of 
all deaths are related to cancer. The morbidity and prevalence of cancer makes it important in 
terms of general health, since a large amount of money is spent on this disease every year and 
the costs associated with the high number of lost human lives are incalculable. Oral cancer is 
among the ten most common cancers worldwide and ranks 4th in males. The incidence of 
oral cancer in South Africa was 3% of all diagnosed cancers in the period 1988-1995. The 
male to female ratio was 2.8:1 for all the population groups (Hille and Shear, 2001). 
Epidemiological evidence shows that the incidence of head and neck cancer increases with 
age. In Europe, 98% of the patients diagnosed with this group of diseases are aged over 40 
years. Although head and neck cancer rarely affects young patients, involving only 4% to 6% 
of persons aged below 40 years, reports indicate that this incidence has increased in a number 
of countries (Iamaroon et al., 2004). Diverse histological types of tumours are found in the 
oral region. Oral squamous cell carcinomas make up the vast majority of these cancers and 
arise from mucosal surfaces throughout this anatomic region (Ragin et al., 2007; Ologe et al., 
2005). Oral cancer is strongly associated with certain environmental and lifestyle risk factors 
including tobacco, alcohol, and certain strains of the (mainly sexually transmitted) Human 
Papillomavirus. Data from Africa is however limited to a few hospital registries and it is 
therefore difficult to extrapolate the true incidence in these countries. 
The purpose of this study is to obtain data on age standardised incidence rates of oral cancer 
in South Africa over the last seven years. It is also aimed at determining if there have been 
any changes in the trends of this cancer since the last reports.  
 
 
 
 
CHAPTER 2 
LITERATURE REVIEW 
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Introduction 
Head and neck cancer (HNC) is a collective term based on anatomical and topographic 
definitions for describing malignant tumours arising from the mucosal surfaces of the upper 
aerodigestive tract, salivary glands, skin, gnathic and craniofacial bones, internal soft 
structures of head and neck including vessels, lymphoid structures, neural, adipose and 
connective tissues, and (neuro) endocrine tissues e.g. thyroid, parathyroid, etc (Davies and 
Welch, 2006). The most common histological type is squamous cell carcinoma which occurs 
in the oral cavity, oropharynx, hypopharynx and larynx and as metastatic tumours in the 
lymph nodes (Alvarenga et al., 2008; Vokes et al., 1993; Pai and Westra, 2009; Ragin et al., 
2007). 
Epidemiology 
The epidemiology of HNC receives limited attention in the general medical literature (Davies 
and Welch, 2006). Worldwide, an estimated 644,000 new cases of head and neck cancers are 
diagnosed each year, of which two-third occurs in developing countries (Marur and 
Forastiere, 2008). 
In the United States, 45,600 new cases of head and neck squamous cell carcinoma were 
diagnosed in 2007, accounting for 3.2% of all incident malignancies and 2.2% (12,460) of all 
cancer deaths (Jemal et al., 2005). Between 1973 and 1998, the incidence rate of oral cancer 
in the United States was reported to average 2.7 new cases per 100 000 population (Carvalho 
et al., 2005). Men are affected three times more than women and the African Americans are 
affected more commonly than the white population (Marur and Forastiere, 2008; Hayat et al., 
2007). In Kenya however, the incidence of oral cancer for the period of 1978-1997 was 
estimated at 2-3% of all malignancies (Onyango et al., 2004), which is the same as reported 
in the seventies (Onyango et al., 1980).  
In the case of South Africa, several papers on age standardised incidence rate have been 
published. An age standardised incidence rate of 4.1 per 100 000 per year for African males 
and 1.5 per 100 000 per year for African females was reported between 1953 and 1955 
(Oettle`, 1966, cited by Hille et al., 1996). Intra oral cancer in South Africa between 1988 
and 1991, accounted for 5.0% and 1.8% of all cancers in males and females respectively. The 
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incidence rate among men and women in the different population groups respectively was 
9.05 and 1.75 (black); 5.24 and 6.66 (Asian); 13.13 and 3.5 (coloured); and 8.06 and 3.18 
(white). Asian women had the highest incidence among the females (Hille et al., 1996). The 
age standardised incidence rate of oral cancer for the period 1993-1995 for males and females 
respectively in South Africa was 6.17 and 1.10 per 100 000 per year for blacks, 8.03 and 3.67 
per 100 000 per year for whites, 4.49 and 8.88 per 100 000 per year for Asians and 8.85 and 
1.94 per 100 000 per year for coloureds (Hille and Shear, 2001).  
Among the Zimbabwean population, the age standardised incidence rate for oral cancer for 
the period of 1988-2000 for male and female was 1.09 and 0.51 per 100 000 per year with an 
average of 0.79 exclusive of lip cancer (Marimo and Hille, 2006). A Congolese study in the 
years 1958-1994, reported the incidence of oral squamous cell carcinoma as 2.1% of all 
cancers (Kayembe and Kalengayi, 1998). Incidence of oral cancer for 1988-1992 for males 
and females in Algeria was 1.1 and 0.3 and in Uganda during the same period was 1.2 and 1.9 
per 100 000 per year (Franceschi et al., 2000). 
Studies have shown marked differences in incidence of oral cancer by race. African 
American males have a higher incidence of oral and oropharyngeal cancers than Caucasian 
males – 20.7 versus 16.2 per 100 000 respectively, and the mortality rates being 
approximately twice as high as for white males (Murdock and Gluckman, 2001; Ries et al., 
2005). 
The five-year survival rate in United States is better for whites than for African-American 
patients. A study on cancer trends (Hayat et al., 2007) demonstrated the rates to be 61%-64% 
versus 40%-52%; and in another study 61.8% versus 39.5% (Ries et al., 2005). The 
worldwide five – year survival rate from oral cancer is generally less than 50%, with females 
tending to survive longer than males. These statistics remained unchanged for more than 
three decades (Ragin et al., 2007). Although there is a high cure rate for early oral cavity 
cancers, most patients present with advanced disease. The worldwide survival rate of oral 
cancer is among the lowest of the major cancers (Clayman et al., 2003). 
The incidence of oral cancer shows geographic and ethnic variations. According to the 
GLOBOCAN series of the International Agency for Research on Cancer (IARC), the 
estimated worldwide age standardized incidence for oral cavity cancer in the year 2002 were 
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6.3 per 100 000 for males and 3.2 per 100 000 for females (Parkin et al., 2005). Data from the 
GLOBOCAN program indicated that Asia had the highest number of cases of head and neck 
cancer for both males and females. The highest age standardised incidence rate (ASIR) of 
head and neck squamous cell carcinoma in 2002 among males was reported in Somme, 
France, ASIR of 46.2 per 100 000 and that of females 23.9 per 100000 in Pakistan. In 2002, 
the lowest rates for both males and females were reported from Valdivia, Chile (Hashibe et 
al., 2010). Varying incidence rates among different race/ethnic groups the between 1992 and 
2004 were also reported by the Surveillance, Epidemiology, and End Results (SEER) 
program of the National Cancer Institute (NIC). The rates for males versus females were as 
indicated; non Hispanic (7.1 vs 3.3), black (8.6 vs 2.7), American Indian (4.2 vs 2.4), 
Asian/Pacific Islander (3.6 vs 2.1) and Hispanic Latino (3.8 vs 1.8), (Brown et al., 2010). All 
rates were calculated per 100 000. 
Risk factors 
The aetiology of head and neck cancer is multifactorial with no single agent or factor being 
clearly defined as being causative for oral cancer. In an article on risk factors for oral cancer, 
the risks were classified as major risk factors, emerging risk factors, and cited controversial 
factors with no scientific evidences (Warnakulasuriya, 2009a).           
Major risk factors 
Tobacco and alcohol 
 Chronic tobacco smoking and alcohol consumption are well established life-style associated 
risk factors for the development of head and neck squamous cell carcinoma. Heavy tobacco 
users have a 5 to 25-fold higher risk of developing head and neck cancer than non-smokers 
(Goldenberg et al., 2004). 
Oral cancer is the most common form of cancer in certain parts of Africa and Asia. The 
frequently aetiological factors associated are endemic tobacco smoking and chewing of 
tobacco and chewing betel quid (Hashibe et al., 2005). Descriptive studies from Sudan 
suggest that oral cancer rates in males are high, linking this to the high incidence of 
“Toombak” - a product of oral snuff mixed with sodium bicarbonate (Idris et al., 1995). 
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More so, numerous studies have shown that tobacco and alcohol use increases the risk of oral 
cancer in a dose response fashion and the joint effects are synergistic. Evidence associating a 
particular type of alcoholic drink with different effects on oral cancer is not clear (Murata et 
al., 1996; Lewin et al., 1998; Talamini et al., 2002; Castellsague et al., 2004 ). In Spain, a 
study on alcohol and tobacco in oral carcinogenesis showed that all forms of tobacco 
increased the risk for oral cancer development. Smokers of black tobacco had a 3.3 fold 
increase in the risk of developing oral cancer than smokers of blond or mixed tobacco. 
Tobacco smoking only and alcohol consumption only was associated with a moderate 
increase in cancer risk. Tobacco smoking and use of alcohol simultaneously had a 13-fold 
increase in the risk of developing oral cancer (Castellsague et al., 2004). There are other 
cultural and habitual risk factors which predispose to the development of oral cancer. These 
include use of smokeless tobacco in the United States and Northern Europe, chewing the 
Betel-quid or Areca nut in India and some parts of Southeast Asia and South Africa. In 
Yemen and parts of the African continent, chewing of Khat is commonly practised 
(Goldenberg et al., 2004). Betel-quid is associated with the development of oral submucous 
fibrosis, a premalignant condition. Individuals affected by submucous fibrosis have a 19 fold 
higher risk of developing oral squamous cell carcinoma (Warnakulasuriya et al., 2002). In 
United States, African Americans have a higher incidence rate for tobacco related cancers 
than the white population (Johnson, 2001). 
Human Papillomavirus 
Accumulating evidence suggests that human papillomavirus (HPV) is a risk factor in the 
aetiology of head and neck cancers. The subtypes 6 and 16 are associated with increased risk 
in cancer of posterior tongue and tonsil (Schwartz et al., 1998). Epidemiological and 
molecular biology studies have suggested that HPV infection may be associated with 25% of 
all head and neck carcinomas and 60% of oropharyngeal carcinomas (McKaig et al., 1998; 
Gillison, 2004). The results of a case control study conducted by the International Agency for 
Research on Cancer point to a likely role of HPV in the aetiology of oropharyngeal and 
cancers of the oral cavity. Herrero et al. (2003) demonstrated that 3.9% of 766 oral cavity 
cancers and 18.3% of 142 oropharyngeal cancers tested positive for HPV DNA. The human 
papillomavirus related cancers were more frequent in the oropharynx and tonsil and also 
among non smokers than in smokers (Gillison, 2004; Herrero et al., 2003). Conversely, 
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several studies reported varying frequencies of HPV involvement in oral cancer. These 
results may have been attributed to the population of study, type of specimen and the 
detection method applied (Shah, 1998; Mork et al., 2001).    
Trauma 
Chronic trauma of the oral mucosa, together with other factors, has been suggested to be an 
important risk factor in patients with oral cancer diagnosis. Piemonte et al. (2010) have 
reported an increased risk (OR=5.5) of developing oral cancer in the presence of longstanding 
oral mucosal trauma.   
Emerging risk factors 
Diet and nutrition 
Dietary factors are important risk factors for oral and pharyngeal cancers. Several 
epidemiological studies have linked these cancers with vitamin A deficiency and with iron 
deficiency associated with the Plummer Vinson syndrome (Wahlberg et al., 1998). A meta-
analysis on observational studies investigating the effects of fruit and vegetable consumption 
on oral cancer concluded that a daily portion of fruit and vegetables is associated with a 
significant reduction in the risk of oral cancer (Pavia et al., 2006). Consuming three or more 
portions of fruit and vegetable during childhood significantly reduces the risk of oral cancer 
compared to those consuming two portions or less and this may be an important factor in 
patients affected by cancer at a younger age (Llewellyn et al., 2004). 
Immunosuppression  
An increase in lip cancer has been reported in patients who have undergone renal 
transplantation and it was attributed to immunosuppression (King et al., 1995, Grulich et al., 
2007). Lip cancer has also been shown to have a strong relationship with exposure to 
ultraviolet component of sunlight. This predominates in people with light complexion and 
those involved in outdoor occupation such as farmers and sailors (Neville et al., 2009). 
Socio-economic status       
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Low socio-economic status in terms of low income, level of education and occupation class 
increased the risk for oral cancer across the world (Conway et al., 2008). 
Cited controversial factors with no scientific evidence 
Human immunodeficiency virus (HIV) infection 
Immunosuppression in HIV infection has been anticipated to increase the risk for oral cancer. 
Although HIV/AIDS is associated with a number of malignancies but the pandemic has not 
influenced the pattern of oral cancer in Kenya. The authors speculated that the HIV 
associated cases of oral squamous cell carcinoma had not risen to large numbers to influence 
the pattern of oral cancer in the country (Onyango et al., 2004). This study did not indicate 
the frequency of the other categories of oral malignancies.  
In Kenya, a study involving 200 HIV-infected patients showed that oral Kaposi’s sarcoma 
accounted for 68%, squamous cell carcinoma 17%, non Hodgkin’s lymphoma 13% and 
Burkitt’s lymphoma 2% of head and neck neoplasms. Another finding was that the patients 
were affected by the malignancies at a younger age than in non-HIV infected population 
(Butt et al., 2008). Based on studies done so far, there is no epidemiological evidence to 
proof association between HIV/AIDS and oral cancer (Shiboski et al., 2009).  
Other cited factors 
Other cited factors without scientific evidence are heredity and familial risk, marijuana 
smoking and alcohol in mouthwashes (Warnakulasuriya, 2009a). 
Oral cancer in young people 
Epidemiological evidence shows that the incidence of head and neck cancer increases with 
age. In Europe, 98% of the patients are aged over 40 years. It has been documented that this 
type of tumour is rare in young people, involving only 4% to 6% of persons aged below 40 
years, although the incidence has increased in a number of countries (Iamaroon et al., 2004). 
Increase in the incidence of oral cancer in the young (less than 45 years) has been reported in 
the United States of America, England and Scotland (Robinson and Macfarlane, 2003; 
Llewellyn et al., 2003; Schantz and Yu, 2002). In Scotland, a 31% rise in the incidence of 
oral cancer in young people was reported between 1989 and 1996. Although majority of the 
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young people had a history of alcohol consumption and smoking, these risk factors did not 
appear to be important. The researchers concluded that other factors such as genetics might 
have played an important role in oral cancer in this group of patients (Robinson and 
Macfarlane, 2003). High incidence of oral cancer before the age of 35 years could be due to 
increased use of different forms of tobacco (Johnson, 2001). 
A study to assess the changing trends in oral squamous carcinoma for the period 1971 to 
2006 at Emory University, USA, reported that 5% of 1919 patients were less than 40 years 
old. There was a significant increase in number of cases reported in younger population from 
1970s to 1980s (2.5–7.59%, p=0.003) and a plateau from 1990s to 2001 – 2006. The average 
age at presentation was 32.5 years and there was no difference between males and females. 
These results were contrary to those reported older individuals where females were 
approximately five years older than males (Müller et al., 2008). In addition, there was a 
notable increase in cancer of the mobile tongue among the young individuals compared to the 
older individuals. A 62% increase of head and neck cancer was reported in young American 
individuals when the periods 1973 – 1984 and 1985 – 1997 were compared (Schantz and Yu, 
2002). The increase was in part attributed to the rise in tongue cancer. Similarly, a significant 
increase (62.1%) in the incidence of squamous cell carcinoma of the tongue was reported in 
the young cohort compared to 27.4% in those older than 40 years during 1990–2001 (Müller 
et al., 2008). The reason for the preference of squamous cell carcinoma for this site has not 
been elucidated. 
The possibility of a genetic predisposition to oral cancer is suggested by its sporadic 
occurrence in young adults and in non-users of tobacco and alcohol. Occurrence of cancers at 
younger age is associated with hereditary factors (Lund and Howard, 1990; Hirota et al., 
2008; Llewellyn et al., 2003).   
Carcinogenesis 
Many gene alterations have been implicated in the development and progression of oral 
squamous cell carcinoma. Tumour suppressor genes control cellular proliferation and a 
variety of other processes important for tissue homeostasis (Hollstein et al., 1994). p53 has 
been identified as an important tumour suppressor gene that repairs a potentially malignant 
cell or destroys it by apoptosis (Scully and Bagan, 2009). Anomalies of proto-oncogenes and 
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inactivation of tumour suppressor genes are involved in the multi step process of 
carcinogenesis. Loss of heterozygosity in the tumour suppressor genes is associated with the 
transformation of a normal cell to dysplastic one (Prime et al., 1997). A p53 mutation in 
tumours is associated with a poor prognosis and its detection may assist clinicians in 
treatment planning (Hollstein et al., 1994). An individual’s genotype determines their 
immune response and this may influence in development of oral squamous cell carcinoma 
(Scully and Bagan, 2009).  
Oncogenes play an important role in the initiation and progression of carcinogenesis (Neville 
et al., 2009). Epidermal growth factor receptor is over expressed in up to 80-90% of head and 
neck cancer. Elevated level of epidermal growth factor is a prognostic marker correlating 
with increased tumour size, increased risk of recurrence, and reduced response to radiation 
(Molinolo et al., 2009). Emerging information on the nature of mechanisms involved in 
progression of head and neck cancer could be translated into clinically relevant diagnostic 
and treatment modalities for the care of oral squamous cell carcinoma patients (Molinolo et 
al., 2009). 
In conclusion, it is evident that the cause of oral squamous cell carcinoma is multifactorial 
and complex. Each of the individual factors reviewed above is not sufficient to cause cancer 
but are associated with an increased risk of the development of cancer. Socio-economic, 
cultural and geographic variables are possible confounding factors (Dobrossy, 2005). 
 
 
 
 
 
 
CHAPTER 3 
AIMS AND OBJECTIVES 
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 Aims 
This study aims at determining the incidence and pattern of distribution of oral cancer in 
South Africa over a period of 7 years, from 1996-2002.  
Objectives 
It is the purpose of this study to: 
1. Determine the age standardised incidence rate (ASIR) of oral cancer by age, gender, 
race and site. 
2. Determine the lifetime risk to develop oral cancer of the population under study. 
3. Describe the incidence of cancers of the oral cavity and compare these to the previous 
studies. 
HYPOTHESIS 
 The overall incidence of oral cancer has been rising in South Africa and increasingly affects 
the younger population.  
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
STUDY DESIGN AND METHODOLOGY 
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Study design 
This was a retrospective descriptive study using routine data from the population based 
National Cancer Registry of South Africa during a period of 7 years. 
Population/sample  
This included all the patients in South Africa diagnosed with oral cancers from January 
1996 to December 2002, a total of 9702 cases.   
Data collection   
Records of all cases of oral cancer from 1996 to 2002 were obtained from the National 
Cancer Registry (NCR), previously managed by the South African Medical Research 
Institute (SAMRI) until 2003 and now based at the National Hospital Laboratory Services 
(NHLS). The NCR is a passive pathology-based surveillance system and collects details of 
cases with histologically and/or cytologically confirmed cancer from copies of pathology 
reports confirming a cancer diagnosis which are submitted voluntary by all public and 
private pathology laboratories throughout South Africa (Sitas, 1995, cited by Hille et al., 
1996). The raw data for the reported cancer cases for the years 1996 to 2002 included 
those from the lip, mouth, tongue, gingiva, oropharynx, floor of mouth, tonsil, palate, 
nasopharynx, hypopharynx, salivary glands and pharynx.  
These data had been digitalised using the CanReg version software, designed by the Unit 
of Descriptive Epidemiology of the IARC which includes the ‘duplicate and person 
search’ module for data validation and identification of duplicate entries. The information 
recorded on each case in the raw data included a registration number that identified the 
patient, the year of diagnosis, diagnosis date, age, sex, population group, incident date, 
morphology and topography of cancer and the International Classification of Diseases - 10 
(ICD - 10) as shown in appendix I. 
 
 
Data analysis 
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The anatomical sites (topography) included in this study were classified into 8 groups as 
follows: 
Floor of mouth Floor of mouth NOS, anterior floor of mouth 
Tongue  Base of tongue NOS, tongue NOS, ventral surface of tongue NOS, 
border of tongue, anterior 2/3 of tongue NOS, dorsal surface of tongue 
NOS, lingual tonsil. 
Lip Lip NOS, mucosa of lower lip, external lip NOS, external lower lip, 
external upper lip 
Gingiva Gum NOS, lower gum, and upper gum 
Palate Palate NOS, soft palate NOS, hard palate, and uvula 
Tonsil Tonsil NOS, tonsillar fossa, and tonsillar pillar 
Mouth Mouth NOS, cheek mucosa, retromolar area, and vestibule 
Oropharynx Oropharynx NOS and vallecula 
 
The gender was classified as males, females and unknown. The population groups were 
Asian, African, Coloured, White, and unknown while the age distribution was put in 5 – 
year groups from 0-4 to 85+ and “unknowns”. 
The histomorphology was grouped into four categories. The group classified as squamous 
cell carcinoma was used for calculating the age standardised incidence rates. The other 
malignant neoplasms in the sites included in this study were grouped as carcinomas (other 
nonsquamous cell carcinomas), sarcomas and other malignancies.  
The squamous cell carcinoma group included adenosquamous carcinoma, carcinoma NOS, 
carcinoma undifferentiated NOS, carcinoma anaplastic NOS, basaloid squamous cell 
carcinoma, large cell carcinoma NOS, papillary squamous cell carcinoma, spindle cell 
carcinoma NOS, squamous cell carcinoma with horn formation, squamous cell carcinoma 
adenoid, squamous cell carcinoma clear cell type, squamous cell carcinoma keratinizing 
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NOS, squamous cell carcinoma large cell non keratinizing NOS, squamous cell carcinoma 
microinvasive, squamous cell carcinoma NOS, squamous cell carcinoma small cell non-
keratinizing, squamous cell carcinoma spindle cell, verrucous carcinoma, basaloid 
carcinoma and malignant neoplasm. The latter category was included in this group since the 
simplified NHLS SNOMED reporting codes are not specific for histological subtypes and 
most often the corresponding malignancies are squamous in nature.  
Population data was derived from the corresponding National Census results published 
online (Statistics South Africa, 2004). The 1996 and 2001 population census data were used 
to calculate the weighted mean population size. The estimated population size for each 
population group per year was calculated by linear interpolation (appendix III). The 
population pyramid for the year 2000 was constructed in power point (Microsoft) using the 
extrapolated population data from the 1996 and 2001 census report (Statistics South Africa, 
2004). The data were tabulated using an Excel (Microsoft TM) spreadsheet for each year, 
population group and gender. The crude rate, age specific morbidity rate, adjusted age 
specific incidence rate, cumulative rate and cumulative (lifetime) risk for oral cancer was 
calculated. Using the direct method described by the IARC (Waterhouse et al., 1976), the 
adjusted age specific incidence rates were standardized against world population and 
recorded as the incidence per 100 000 population per year; adjustments for unknown age 
was made.  
Inclusion criteria 
Records of cases from the anatomical sites selected for this study with a diagnosis of 
squamous cell carcinoma and the other diagnoses included in this group. 
Exclusion criteria 
Records of cases categorised as carcinomas, sarcomas and other malignancies. 
 
CHAPTER 5 
RESULTS 
 
 
 
 
28 
 
 
5.1 Frequency of new squamous cell carcinoma cases 
In the period 1996 – 2002, there were 9702 new cases of oral squamous cell carcinoma 
involving all sites included in this study. There was slight annual variation in the frequency 
of new cases over the 7 years. The highest number of reported cases occurred during 1996 
(15.2%), while the year 2000 recorded the lowest (11.5%). Consistent numbers of reported 
oral squamous cell carcinomas were reported between 1996 – 1998 and 2001 – 2002 (table 
1 and figure 1).  
  1996 1997 1998 1999 2000 2001 2002 
Male 1159 1077 1069 1013 854 969 937 
Female 318 324 350 325 257 295 325 
Total 1477 1401 1419 1338 1111 1264 1262 
 
Table 1. Frequency of oral and lip cancer cases recorded per year. 
 
Figure 1. Bar graph showing annual distribution of oral and lip cancer for all 
population groups. 
 
5.2 Gender distribution 
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The majority of oral squamous cell carcinoma cases diagnosed in the seven year period 
occurred in males except in the Asian population where the females were slightly more 
affected (figure 2). Among the males, the African population represented 3500 (59.5%) of 
the cases of oral cancer. The male to female ratio for all groups was 3:1, the Africans 
having a ratio of 4.5:1 (table 2). 
 
Figure 2. Bar graph showing oral and lip cancer distribution by gender and 
population group 1996 – 2002. 
 
 
 
 
 
 Male Female Oral cancer 
Ratio M:F  Oral Lip Oral Lip 
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African 3500 66 737 65 4.5:1 
Coloured 840 54 290 28 2.8:1 
White 1436 595 689 127 2.5:1 
Asian 105 7 127 3 1:1.2 
Total 5881 722 1843 233 3:1 
           
Table 2. Frequency of oral and lip cancer and the gender ratio 1996 – 2002. 
5.3 Age distribution 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Age distribution of males and females in total population 2000. 
 
Figure 3 shows the distribution of the total population in the year 2000. The females were 
more than the males and there were fewer number of children in the 0 – 4 age group 
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compared to the 5 – 9 age groups. This difference could be attributed to increased prenatal 
deaths or a decline in the fertility rates. 
The age distribution for oral cancer cases for this study population was grouped in 5-year 
categories and it showed a progressive increase in the number of cases with age (figure 4).  
 
Figure 4. Bar graph depicting oral cancer distribution by 5-year age groups for males 
and females 1996 – 2002. 
From the 55 – 59 age groups onward, the number of oral cancer cases showed a declining 
trend which corresponds to the population pyramid. 
The African and Asian males showed a peak in the 50 – 54 age groups while the coloured 
and white males experienced their peak in the 55 – 59 age groups as is apparent in figure 5.  
The African females showed a peak in the 55 – 59 age group; coloured and whites in 60 – 
64 age group and the Asians in the 65 – 69 age group as in figure 6. 
Males in the African, coloured and white population groups had their peak occurrence five 
years earlier than the female counterparts while the Asian males had their peak incidence 10 
years earlier than the females.  
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Figure 5 Distribution of oral cancer by 5-year age groups for each population group 
(males) 1996 – 2002. 
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Figure 6. Distribution of oral cancer by 5-year age groups for each population group 
(females) 1996 – 2002. 
In the 0 – 39 age group, the African males had 149 cases of which 121 were in 30 – 39 age 
groups. The other 3 population groups had a total of 69 cases in 0 – 39 groups (figure 7). 
 
Figure 7. Line graph for trends of oral cancer by 5 – year age groups for all males. 
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Figure 8. Line graph for trends of oral cancer by 5 – year age groups for all females.  
The total number of cases in the 0 – 39 years age group for the females was 75, of which 
52% were African females. During the study periods and among the different population 
groups, there was no increase in the number of new cases in the younger population (<45 
years).  
The total number of cases in both gender groups was lower in 2000 compared to the other 
years. There was no indication of a decrease in the total population  shown in the population 
pyramid in figure 3. The population distribution was compared to that of 1999 and 2001 
(appendix VIII and IX). The trends of oral cancer for males and females in the African and 
white population groups is shown in appendix 9 and 10 respectively. The white males had a 
constant trend while the other three groups showed a rising trend.  There was no shift 
towards the younger age groups. 
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5.4 Site distribution 
The distribution of all reported squamous cell carcinoma cases at different sites over the 
study period is shown in figure 9.  
 
Figure 9. Bar graph showing the distribution of oral squamous cell carcinoma by site 
and gender for all population groups. 
The tongue had the highest number of reported cases (33.9%), followed by the mouth 
(28.8%) and the oropharynx had the lowest number (1.2%). Oropharyngial and tonsilar 
squamous cell carcinomas in both males and females showed a rise in numbers from the age 
of 45 years (figures 10 and 11). A similar trend was recorded for oral cancer. There was no 
shift of the cancer cases in these two sites towards the younger age groups (figures 10 and 
11). Intraoral cancer in this study referred to oral cancer as indicated earlier excluding 
oropharynx and tonsil cases. 
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Figure 10. Distribution of oropharyngeal and tonsilar cancer combined, and intraoral 
cancer for all males. 
 
Figure 11. Distribution of oropharyngeal and tonsilar cancer combined, and intraoral 
cancer for all females. 
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Lip cancer 
Lip cancer cases were recorded in much younger age groups than oral cancer. It showed a 
slight rise with increasing age among the males. Among the females, the majority of the 
cases occurred between 60 years and 80 years of age (figure 12). Females represented 
22.4% of the total 1038 cases.  
 
Figure 12. Distribution of lip cancer by 5-year age groups for males and females 1996 
– 2002. 
There was a marked difference in the number of lip cancer cases among males. The 
majority of cases occured in the white population – 595 of 722 cases(82.4%). A decline was 
noted as illustrated in figure 13. The white females also had the highest number of lip 
cancer cases and showed a similar decline. This is in contrast to oral cancer that was more 
evident in the African population. Lip cancer in the Asian population remained unchanged  
(figure 14). 
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Figure 13. Line graph for trends of lip cancer in all males.  
 
Figure 14. Line graph for trends of lip cancer in all females. 
 
 
 
 
39 
 
5.5 Incidence rates 
Age specific morbidity rate  per 100 000 per year for males was highest in the coloured 
population (figure 15). The range for all males was 0.1 – 1.7 per 100 000 per year. The peak 
for the age specific morbidity rate was 50 – 54 years for Africans; Asians 60 – 64 years; 
coloured 60 – 64 years; white 55 – 59 years. The graphs for age specific morbidity rates for 
males in the different population groups are in appendix XII.  
The age specific morbidity rate for females was highest in the Asian population (figure 16). 
The range was 0.1 – 1.0 per 100 000 per year. The peak was in the 50 – 54 years age group 
for Africans; Asians 65 – 69 years; coloured 50 – 54 years and 70 – 74 years; whites 60 – 
64 years. The graphs for age specific morbidity rates for females in the different population 
groups are in appendix XIII.  
The African males and females had the peak age specific morbidity rate earlier than the 
other population groups.  
 
 
 
Figure 15. Age specific morbidity rates per 100 000 per year for oral cancer in males. 
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Figure 16. Age specific morbidity rates per 100 000 per year for oral cancer in females. 
 
Age adjusted incidence rates (males) 
Figure 17 show the age adjusted incidence rates for the males for oral cancer from 1996 – 
2002. The range of the results was 1.87 to 13.40 per 100 000 per year. The lowest age 
adjusted incidence rate was reported in the Asians while the highest was in coloured 
population groups. The rates for the Africans showed a gradual decline from 1996 to 2002. 
The age adjusted incidence rate over the study period for all males was 6.19 per 100 000 per 
year. The rates were decreasing over the years but the for coloured group it remained 
constant. 
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Figure 17. Line graph showing age adjusted incidence rate per 100 000/year for oral 
cancer in males. 
Age adjusted incidence rates (females) 
The range for age adjusted incidence rate  among the females was 0.69 to 6.97 per 100 000 
per year. This was much lower compared with the rates for the males. The Asian women 
generally had higher age adjusted incidence rate  while the lowest rates were among African 
women (figure 18). The age adjusted incidence rate over the study period for all females 
was 1.60 per 100 000 per year. The rates demonstrated a declining trend except for the 
coloured group which had a slight rise. 
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Figure 18. Line graph showing age adjusted incidence rate per 100 000 per year for 
oral cancer in females. 
The cumulative lifetime risk of developing oral cancer varied markedly between the 
genders. The cumulative lifetime risk for coloured males was 1:49 while the Asian females 
had 1:120, the highest for each gender. 
Lip cancer 
The age standardized incidence rate for the lip was calculated separately because of the 
likelihood of overlap of skin cancers. The white males had a consistently high age 
standardized incidence rate compared with the other population groups over the 7 years and 
the Asian males reported the lowest values. The range of the age standardized incidence rate 
was 0.20 – 3.92 per 100 000/year (figure 19). 
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Figure 19. Line graph for age standardized incidence rate for lip cancer in males. 
Among the women, age standardized incidence rate for lip cancer  were high in the white 
population followed by the African women (table 6 and figure 20). The peak among 
Africans was in 1999. The Asian women had very low age standardized incidence rates, 
which was in contrast to the high rate recorded for intraoral cancer.The distribution of  age 
standardized incidence rates for lip cancer appeared to follow similar pattern in males and 
females for the population groups, that is in decreasing order white, African, coloured and 
Asian population groups. 
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Figure 20. Line graph for age standardized incidence rate for lip cancer in females. 
Age standardized incidence rate for oral and lip cancer combined  
The age standardized incidence rate per 100 000 per year for each population group over the 
7 years period ranged from 0.97 to 11.54. The age standardized incidence rates for males vs 
females was: Asians 3.60 vs 4.10; Africans 6.14 vs 0.97; coloured 11.54 vs 3.13; white 
11.24 vs 3.70. The age standardized incidence rates for all the sites combined for each year 
indicated high rates among the white and coloured population and lower rates in the African 
and Asian population (figures 21 to 24). Women had lower rates than the men except for the 
Asian women. The 95% confidence intervals were wide among the Asians reflecting the 
few number of cases over the study period. 
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Estimates of the ASIR for oral and lip cancer combined and 95% confidence intervals.
 
Figure 21(a) 
 
Figure 22(a) 
 
 
Figure 21(b) 
 
Figure 22(b) 
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Figure 23(a)       Figure23(b)   
 
 Figure 24(a)      Figure 24(b) 
Figures 21 – 24 illustrated the 95% confidence intervals for the age standardized incidence 
rates for oral cancer in males and females in the four population groups. 
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CHAPTER 6 
DISCUSSION 
The total number of oral squamous cell carcinoma cases as recorded by the National Cancer 
Registry over the 7 year period was 9702. This was 8.4% higher than the 8950 reported 
cases in 1988 – 1995 study on epidemiology of oral cancer in South Africa. Females 
represented 23.69% and males 76.31% in this study while in 1988 – 1995 there was 26.34% 
and 73.66% respectively (Hille and Shear, 2001). The male to female ratio was 1:3 for this 
study and for 1988 – 1995 periods it was 1:2.8. The gender ratio conformed to the 
worldwide trends being within the ranges reported in other studies (Marur and Forastiere, 
2008; Neville et al., 2009; Iamaroon et al., 2004).  
6.1 Oral cancer 
The age specific morbidity rates had a range of 0.1 – 1.7 per 100000 per year in males. The 
rates among the men were highest in the coloured group with almost no overlap with other 
population groups. The Asians had a lower rate than the Africans.  Among the females, the 
range was 0.1 – 1.0 per 100000 per year. Asian women had the highest rates with some 
overlap with the whites, and the African women had a consistently low rate. This was a 
similar trend to the previous South African studies (Hille and Shear, 2001; Hille et al., 
1996). The early peak for African males (50 – 54 years) and the later peak in coloured and 
Asians (60 – 64 years) could be attributed to early exposure to causative factors or varying 
habits. The coloured population had more cancer cases from 65+ years than the other 
population groups. The African females had the peak rate at 50 – 55 years while Asians had 
the peak at 65 – 69 years. This probably was a result of the duration it takes for the effects 
betel nut chewing to cause dysplastic changes in the oral cavity. Betel nut chewing is a habit 
prevalent among Asian females. 
The age adjusted incidence rates in this study for males had a range from 1.87 (Asian) to 
13.40 (coloured) per 100 000 per year, and 6.19 for all males. This showed a decrease of 
oral cancer among the Asian male population and a rise among coloured males. In the 1993 
– 1995 period, the age adjusted rates were 4.49 (Asian) and 8.85 (coloured) per 100 000 per 
year, and 8.15 for all males (Hille and Shear, 2001). Among the females, age adjusted 
incidence rate in 1996 – 2002 for the African and Asian was 0.93 and 4.19 per 100 000 per 
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year respectively, and 1.60 for all females. There was a decrease compared to 1993 – 1995 
rates of 1.10 and 8.88 for the Africans and Asians, and 2.01 for all females (Hille and Shear, 
2001). The decline in the age adjusted rates in Asian, African and white males, and Asian 
and white females was probably an indication of reduced involvement in habits associated 
with aetiology of oral cancer. The slight rise in coloured females could reflect an increase in 
smoking or other causative habits. The trend in African females did not change; they had a 
low number of cases and lowest rates similar to those reported in previous South African 
studies. Lack of reporting for treatment or lack of involvement in causative habits might 
explain this trend.  
Robinson and Macfarlane (2003) reported an increase in the age standardized incidence rate 
(ASIR) from 9.5 to 11.5 in males and 3.8 to 4.8 per 100 000 per year in females in Scotland 
in 1989-1996; this was slightly lower than South African coloured males (13.40) but higher 
than the rates recorded for South African women (except Asians) in this study. The ASIR 
for males and females in Uganda and Algeria 1988 – 1992 was 1.2 and 1.9, and 1.1 and 0.3 
per 100 000 per year respectively (Franceschi et al., 2000). In Zimbabwe, the ASIR for 
intraoral cancer for the period of 1988-2000 for male and female were 1.09 and 0.51 per 
100 000 per year respectively (Marimo and Hille, 2006). The rates in the three African 
countries are much lower than the South African rates for men and women. A possible 
reason for this could be under reporting especially when using hospital data.  
In 2002, the world age standardized incidence rate for oral cavity cancer for males and 
females respectively was 6.3 and 3.2 per 100 000 per year (Parkin et al., 2002). The rate for 
males was lower than that of coloured and white South African males (10.82 and 8.19) 
respectively but close to that of African males (6.19) for 1996 – 2002. The world rate for 
females was similar to that of South African white females but lower than for South African 
Asian females (4.19) and 2 times the overall rate for all South African females (1.60). 
According to the SEER data (Brown et al., 2010) the black males in the United States had 
the highest age standardized incidence rate (8.6) while in the South African population the 
blacks had a rate of 6.19, with the coloured and white males having 10.82 and 8.19 
respectively. These rates displayed the geographic and cultural differences between the 
South African and United States populations. The age standardized incidence rates per 100 
000 per year for various world populations were compared to those for South African 
population (appendix XIV). 
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Racial differences have been cited in the incidence of head and neck cancer with the 
African American being affected more than the white population for both males and 
females (Marur and Forastiere, 2008; Franceschi et al., 2000). These differences were also 
reflected in our study. African males accounted for 42.26% and white males 22.69% of all 
cases. Africans represented 9.42% and the white females 9.18% of all cases. In the 1988 – 
1995 study, African males represented 47.42% and white males 16.73% of all oral 
squamous cell carcinoma cases (Hille and Shear, 2001). These differences could be 
attributed to social and cultural practices or the fact that the African males were the majority 
in the total population. 
Compared with 1993-1995 period, the cumulative lifetime risk of developing oral cancer 
increased for all groups except the Asians, the decrease however was not remarkable. The 
coloured females showed a marked increase; 1:435 (1993-1995) to 1:162 (1996-2002). The 
rise was likely as a result of increased cigarette smoking in this group. Cumulative lifetime 
risk for coloured males was 1:49, remaining and similar to that reported in previous studies. 
The table comparing our results with previous South African studies is in appendix XV.  
6.2 Age  
 Age distribution of all cases showed a progressive increase in number of new cases with 
increasing age, with a sharp rise from 40-44 years which was followed by a gradual drop 
from the 65-69 age group. An increase in cancer incidence in the 40-50 age groups and a 
decline from the 60-70 age groups has been reported in several studies (Müller et al., 2008; 
Alvarenga et al., 2008). Other studies have reported a rise through to the age of 75 years 
(Carvalho et al., 2005). 
There was slightly lower percentage of young people (less than 45 years) with oral cancer in 
this study compared with a previous South African study 1988 - 1991. In 1996 – 2002, 
11.19% males and 10.04% females were less than 45 years of age while in 1988 – 1991, 
15.6% were males and 14.1% were females (figures calculated from the 1988-1991 study) 
(Hille et al., 1996). This is in contrast with a study carried out in Thailand which 
demonstrated an increase in oral cancer among young people in 1991 – 2000, from 4% to 
12% (Iamaroon et al., 2004). In the study comparing the cases of oral cancer in young 
Americans between 1973 – 1984 and 1985 – 1997, the results showed a 62% increase in 
young people, with tongue cancer being the most frequent (Schantz and Yu, 2002). The 
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constantly low number of oral cancer cases among younger people and in the general 
population could imply that human immunodeficiency virus (HIV) infection has had no 
influence on the occurrence of oral squamous cell carcinoma, considering the high rates of 
HIV infection reported in South Africa. 
When oropharynx and tonsil cancer cases for males and females were tabulated (figures 10 
and 11), there was no evidence of increased cancer cases compared to previous South 
African studies. It showed the same age distribution as intraoral cancer. These results are in 
contrast to a study in Scotland, which showed an increase in oral and pharyngeal cancers by 
31% in males and 16% in females between 1989 – 1996 (Robinson and Macfarlane, 2002). 
Varying proportions of oropharyngeal and tonsillar squamous cell carcinoma cases have 
been associated to the human papillomavirus (Herrero et al., 2003; Gillison, 2004; McKaig 
et al., 1998). The constantly low incidence of oropharyngeal and tonsillar squamous cell 
carcinomas and the high incidence in the older age group in the South African population 
could imply that human papillomavirus does not influence the occurrence of these tumour. 
However, additional and more sophisticated studies would be necessary to confirm this 
inference.  
6.3 Anatomical sites 
The most common site of squamous cell carcinoma was the tongue (33.88%) followed by 
the mouth (28.75%). The lip represented 11.05%. These results were similar to a study 
performed in Kenya that showed the tongue to be the predominant site, followed by the 
mandible, maxilla and lower lip in decreasing frequency (Onyango et al., 2004). Other 
African studies also concurred with these results (Llewellyn et al., 2003; Müller et al., 
2008; Davies and Welch, 2006; Marimo and Hille, 2006; Hirota et al., 2008), so did reports 
among European and United States populations (Warnakukasiriya, S., 2009b). 
A study on incidence and trends of head and neck cancer in America found an increase in 
tongue cancer among those less than 40 years old (Schantz and Yu, 2002). This on the other 
hand is in contrast to our findings where cases of tongue cancer increased from the age of 
40 years and a decline in the 70’s, having a similar trend to the other intraoral sites. 
Although our study was not investigating the etiologic factors of squamous cell carcinoma, 
none of these other studies explained their findings on the predominant sites.  
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6.4 Lip cancer 
The lip lesions are reported separately in some studies owing to the different pathogenesis 
(Hille and Shear, 2001; Carvalho et al., 2005). In this study, the white population had the 
highest proportion of lip cancer, with the males and females representing 82.41% and 
56.95%, and incidence rates of 3.92 vs 0.68 respectively. In comparison to previous studies 
(appendix III and IV, there was a remarkable decrease in the age standardized incidence 
rates among the females compared to the men (Hille et al., 1996; Hille and Shear, 2001). 
High incidence rates in white population compared with non-white population was also 
reported in Canada and Australia (Warnakulasiriya, S., 2009b). 
An important etiologic factor for lip cancer is exposure to ultra – violet irradiation from the 
sun. 
6.5 Oral and lip cancer combined 
The age standardized incidence rate  for all ages and sites 1996 – 2002 for males vs females 
was Asian 3.60 vs 4.10; African 6.14 vs 0.97; coloured 11.54 vs 3.13; white 11.24 vs 3.70. 
The worldwide age standardized incidence rate per 100 000 for several regions in 2000 in 
males and females was reported (Ferlay et al., 2000). Namibia had 34.17 vs 11.71; United 
States of America 9.32 vs 4.35; India 22.4 vs 9.31 and Taiwan 26.98 vs 2.85. The 
worldwide ASIR for the oral cavity cancers was reported as 6.3 and 3.2/100000/year for 
males and females in 2002 (Parkin et al., 2005). 
These worldwide results showed varying rates in men and women compared to those reported 
for this study. This likely reflects variations in geographic distribution and habits related to 
aetiology of oral cancer.  
The 95% confidence interval was used to compare the different population groups. From 
these figures, it can be inferred that there were substantial differences in the age standardized 
incidence rates between the males and females in all groups except the Asians. The 
differences could be significant, but this could not be confidently stated because no statistical 
tests were done. Coloured males had the highest incidence rates like in previous South 
African studies (Hille et al., 1996). 
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CHAPTER 7 
LIMITATIONS OF THE STUDY 
This study utilized data that had been compiled by the National Cancer registry. The 
registry extracts data from the pathology reports sent by private and public laboratories. 
Some laboratories may send incomplete data which may lead to incorrect reporting. 
The compiled report from the National Cancer Registry fell far short of the intended study 
period. The initial aim was to determine the pattern and incidence of oral cancer in South 
Africa 1996 - 2005, but the registry provided data for seven years, 1996 – 2002. Although 
the data provided was used for assessment of the trends, a longer period would have given a 
broader view of any changes occurring in the incidence of oral squamous cell carcinoma. 
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CHAPTER 8 
CONCLUSIONS 
The male to female ratio was 3:1, similar to prior South African studies. The most common 
site for oral cancer was the tongue followed closely by the mouth. 
This study has demonstrated the trends of oral cancer between 1996 and 2002. There was a 
downward trend in the incidence of oral cancer among the Asian, African and white males 
but the coloured males had consistently high incidence rate. Among the females, there was a 
declining trend in the Asians and whites but a rise in the coloured population. The African 
females had a consistently low incidence rate. The varied trends could be an indication of a 
change in their involvement in habits that contribute to occurrence of oral cancer or changes 
in the reporting patterns.  
The incidence rate among coloured males was higher than 1993 – 1995 periods. Although 
the incidence rate in the Asian females in our study was lower incidence than 1993 – 1995 
periods, it remained the highest among the females. There was a notable rise in the 
cumulative lifetime risk among coloured males and females, and a rise in both genders. The 
risk of developing oral cancer for Asian females was 5 times that of the African 
counterparts. 
The incidence rate for South African Asian males was similar to that of Asian/Pacific 
Islander males while the female Asians had double the rate of the Asian/Pacific Islander 
female. The United States male and female blacks higher rates than the South African black 
population.  This was an indication of the worldwide geographic and habits variations in 
distribution of oral cancer. 
There was no evidence of increase in the new cases of tonsillar and oropharynx squamous 
cell carcinoma over the study period in the South African population or a shift towards the 
younger people (aged <45). This could imply that human papillomavirus had not influenced 
occurrence of cancer in these sites in this population. 
The absence of an obvious rise in the incidence of oral squamous cell carcinoma cases in 
the South African population for all ages could imply that the human immunodeficiency 
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virus infection has not had an impact on the occurrence of oral squamous cell carcinoma or 
that the practising of contributing habits remained consistent. 
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APPENDICES 
Appendix I 
ICD-10 NOMENCALTURE OF TOPOGRAPHY: 
MALIGNANT NEOPLASMS OF LIP, ORAL CAVITY AND PHARYNX (C00-C14) 
C00 malignant neoplasm of lip 
 Excludes: skin of lip 
C00.0 External upper lip 
 Upper lip: 
 NOS 
 Lipstick area 
 Vermilion border 
C00.1 External lower lip 
 Lower lip: 
 NOS 
 Lipstick area 
 Vermilion border 
C00.2 External lip, unspecified 
 Vermilion border NOS 
C00.3 Upper lip, inner aspect 
 Upper lip: 
 Buccal aspect 
 Frenulum 
 
 
 
 
65 
 
 Mucosa 
 Oral aspect 
C00.4 Lower lip 
 Lower lip: 
 Buccal aspect 
 Frenulum 
 Mucosa 
 Oral aspect 
C00.5 Lip, unspecified, inner aspect 
 Lip, not specified whether upper or lower: 
 Buccal aspect 
 Frenulum 
 Mucosa 
 Oral aspect 
C00.6 Commisure of lip 
C00.8 Overlapping lesion of lip 
C00.9 Lip, unspecified 
C01 Malignant neoplasm of base of tongue 
 Dorsal surface of base of tongue 
 Fixed part of tongue NOS 
 Posterior third of tongue 
C02 malignant neoplasm of other and unspecified parts of tongue 
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C02.0 dorsal surface of tongue 
 Anterior two-thirds of tongue, dorsal surface 
 Excludes: dorsal surface of base of tongue 
C02.1 border of tongue 
 Tip of tongue 
C02.2 Ventral surface of tongue 
 Anterior two-thirds of tongue, ventral surface 
 Frenulum linguae 
C02.3 Anterior two-thirds of tongue, part unspecified 
 Middle third of tongue NOS 
 Mobile part of tongue NOS 
C02.4 Lingual tonsil 
 Excludes: tonsil NOS 
C02.8 Overlapping lesion of tongue 
Malignant neoplasm of tongue whose point of origin cannot be classified to any one 
of the categories C01-C02.4 
C02.9 Tongue, unspecified 
C03 Malignant neoplasm of gum 
 Includes: alveolar (ridge) mucosa, gingival 
 Excludes: malignant odontogenic neoplasms 
C03.0 Upper gum 
C03.1 Lower gum 
C03.9 Gum, unspecified 
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C04 Malignant neoplasm of floor of mouth 
C04.0 Anterior floor of mouth 
 Anterior to the premolar-canine junction 
C04.1 Lateral floor of mouth 
C04.8 Overlapping lesion of floor of mouth 
C04.9 Floor of mouth, unspecified 
C05 Malignant neoplasm of palate 
C05.0 Hard palate 
C05.1 Soft palate 
 Excludes: nasopharyngeal surface of soft palate 
C05.2 Uvula 
C05.8 Overlapping lesion of palate 
C05.9 Palate, unspecified 
 Roof of mouth 
C06 Malignant neoplasm of other and unspecified parts of mouth 
C06.0 Cheek mucosa 
 Buccal mucosa NOS 
 Internal cheek 
C06.1 Vestibule of mouth 
 Buccal sulcus (upper) (lower) 
 Labial sulcus (upper) (lower) 
C06.2 Retromolar area 
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C06.8 Overlapping lesion of other and unspecified parts of mouth 
C06.9 Mouth, unspecified 
 Minor salivary gland, unspecified site 
 Oral cavity NO 
Appendix II 
Age interval 1 2 3 4 5 6 7 8 Total
01_0 to 4              1    1 
02_5 to 9    4          2    6 
03_10 to 14    4          1    5 
04_15 to 19    7  1      1  3    12 
05_20 to 24    3  15  3    1  6    28 
06_25 to 29  1  10  25  4    3  9    52 
07_30 to 34  4  34  39  5  6  8  29  2  127 
08_35 to 39  11  75  61  6  9  28  60  1  251 
09_40 to 44  42  227  76  27  31  56  172  7  638 
10_45 to 49  89  368  102  49  37  103  315  16  1079 
11_50 to 54  117  526  102  58  71  171  384  24  1453 
12_55 to 59  125  533  105  52  73  129  421  17  1455 
13_60 to 64  92  452  116  49  59  138  413  23  1342 
14_65 to 69  68  372  104  55  55  94  317  10  1075 
15_70 to 74  45  238  100  42  20  61  237  7  750 
16_75 to 79  32  151  84  30  15  33  138  4  487 
17_80 to 84  13  86  55  21  16  9  75  3  278 
18_85+  4  51  41  19  7  9  46  2  179 
(Unknown) 39  146  46  19  17  54  160  3  484 
Total 682  3287  1072  439  416  898  2789  119  9702 
 
Frequency of oral and lip cancer by 5-year age groups and anatomic site  
 
1 – Floor of mouth 
2 – Tongue 
3 – Lip 
4 – Gum 
5 – Palate 
6 – Tonsil 
7 – Mouth 
8 - Oropharynx 
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Appendix III 
Black Males Linear Interpolation    
1996 1997 1998 1999 2000 2001 2002 
1818977 1829571 1840166 1850760 1861355 1871949 1882543 
 
 
Population linear interpolation 
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Appendix IV 
 
Trends of lip cancer in 10 – year age groups for white males 1988 - 1991 
Appendix V 
 
Trends of lip cancer in 10 – year age groups for white females 1988 - 1991 
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Appendix VI 
 
5-year age distribution of oral cancer in all males 1988 – 1991 (Hille et al., 1996). 
Appendix VII 
 
5-year age distribution of oral cancer in all females 1988 – 1991 (Hille et al., 1996). 
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Appendix VIII 
  
 
 
 
 
 
 
                                                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age distribution of males and females in the total population 1999 
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Appendix IX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age distribution of males and females in the total population 2001 
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Appendix X 
 
 
 
 
(a) Trends of oral cancer cases by 5 – year age groups for males 1996 – 2002 
(Africans) 
 
 
 
 
(b) Trends of oral cancer cases by 5 – year age groups for males 1996 – 2002 (White)  
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Appendix XI 
 
 
 
(a) Trends of oral cancer cases by 5 – year age groups for females 1996 – 2002 
(Africans) 
 
 
 
 
(b) Trends of oral cancer cases by 5 – year age groups for females 1996 – 2002 
(Whites) 
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Appendix XII 
 
 
 
(a) Age specific morbidity rates per 100 000 per year for males (Asians) 
 
 
 
 (b)Age specific morbidity rates per 100 000 per year for males (African) 
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(c) Age specific morbidity rates per 100 000 per year for males (coloured) 
 
 
(d) Age specific morbidity rates per 100 000 per year for males (White) 
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Appendix XIII  
 
 
 
 
(a) Age specific morbidity rates per 100000 per year for females (Asian) 
 
 
 
(b) Age specific morbidity rates per 100000 per year for females (African) 
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(c) Age specific morbidity rates per 100000 per year for females (coloured) 
 
 
(d) Age specific morbidity rates per 100000 per year for females (White) 
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Appendix XIV 
  Asian African Coloured White  
  M F M F M F M F M F 
1996 – 
2002 
South 
Africa 3.46 4.19 6.19 0.93 10.82 2.88 8.19 3.23  
1993 – 
1995 
South 
Africa 4.49 4.19 6.17 1.1 8.85 1.94 8.03 3.67  
1992 – 
2004 
United 
States 
Asian/Pacifi
c Islander Blacks 
Hispanic 
Latino 
Non 
Hispanic 
Americ
an 
Indian 
  3.6 2.1 8.6 2.7 3.8 1.8 7.1 3.3 4.2 2.4
 
South Africa 1993 – 1995 (Hille and Shear, 2001), USA 1992 – 2004 (Brown et al.,2010) 
Age standardized rates per 100 000 per year for oral squamous cell carcinoma by 
gender and race/ethnicity  
Appendix XV 
Population group 1988-1991 1992 1993-1995 1996-2002 
Asian male 1:161 1:435 1:167 1:188 
Asian female 1:125 1:233 1:97 1:120 
African male 1:86 1:99 1:122 1:92 
African female 1:445 1:527 1:770 1:596 
Coloured male 1:65 1:60 1:91 1:49 
Coloured female 1:244 1:334 1:435 1:162 
White male 1:104 1:119 1:106 1:71 
White female 1:278 1:345 1:213 1:156 
     
All male 1:91 1:92 1:115 1:83 
All female 1:358 1:400 1:401 
 
1:319 
 
Cumulative lifetime risk for developing intraoral squamous cell carcinoma in the South 
African population for the periods 1996-2002 compared with the previous South 
African studies.  
1988 – 1991 (Hille et al., 1996) 1992, 1993 – 1995 (Hille and Shear, 2001) 
 
 
 
 
 
 
